Trial watch: phase III and submission failures: 2007-2010
Nat Rev Drug Discov
.
2011 Feb;10(2):87.
doi: 10.1038/nrd3375.
Author
John Arrowsmith
PMID:
21283095
DOI:
10.1038/nrd3375
No abstract available
Publication types
News
MeSH terms
Antineoplastic Agents / therapeutic use
Clinical Trials, Phase III as Topic / methods
Clinical Trials, Phase III as Topic / standards*
Humans
Neoplasms / drug therapy
Neoplasms / epidemiology
Treatment Failure*
Substances
Antineoplastic Agents